Head And Neck Cancer (HNSCC Profile)

The "Head and Neck Cancer (HNSCC Profile)" test is performed to assess specific markers associated with head and neck squamous cell carcinoma (HNSCC). The test includes two main components: HPV by PCR: This part of the test uses polymerase chain reaction (PCR) to detect the presence of human papillomavirus (HPV) in head and neck cancer samples. HPV is a known risk factor for certain head and neck cancers, especially those affecting the oropharynx. Detection of HPV in tumor tissue can help guide treatment decisions and provide valuable prognostic information. p16INK4a Immunohistochemistry (IHC): p16INK4a is a tumor suppressor protein, and its overexpression is often associated with HPV-induced head and neck cancers. The test uses immunohistochemical staining to assess the levels of p16INK4a protein in tumor tissue. Elevated levels of p16INK4a can indicate an HPV-related tumor. The combined results of the HPV by PCR and p16INK4a IHC tests help in the diagnosis and characterization of head and neck cancers, particularly those associated with HPV infection. These results play a crucial role in determining the appropriate treatment approach for patients, as HPV-positive tumors may have distinct clinical behavior and response to therapy compared to HPV-negative tumors. Additionally, the test results can provide important information for prognosis and monitoring of the disease.